ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Clinical Use of Anabolics and Hormones
Clinical Use of Anabolics and Hormones
TRT to Supraphysiological Levels for Body Building
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tareload" data-source="post: 215858"><p>For the HAARLEM study above:</p><p></p><p>[URL unfurl="true"]https://www.frontiersin.org/files/Articles/732318/frph-03-732318-HTML/image_m/frph-03-732318-t001.jpg[/URL]</p><h3></h3><h3>Clinical Relevance</h3><p></p><p>Our findings strongly support the cardiotoxic nature of AAS. The changes in cardiac structure and function did not lead to symptoms, however, such as dyspnoea or peripheral oedema, as these were not reported by the subjects. The occurrence of heart failure in users of AAS nevertheless has often been reported (<a href="https://www.frontiersin.org/articles/10.3389/frph.2021.732318/full#B22" target="_blank">22</a>). We hypothesize that cumulative cardiac damage may follow long-standing AAS use when recovery time in between cycles is too short or when AAS are used continuously. Our data could not substantiate the presence of such cumulative damage as we did not observe a relationship between the extent of prior AAS use and cardiac abnormalities at baseline. Of note, our cohort displayed a wide variety of historic AAS use, ranging from no prior use to 8 years of cumulative AAS use, but no subjects had abused androgens continuously for longer than 1 year. It is therefore likely that progression to clinical heart failure only occurs in those athletes with an excessive history of AAS use, or when an athlete has a prior medical condition affecting the heart, e.g., cardiomyopathy.</p><p></p><p></p><p></p><p>Heart Primer and review of above article.</p><p></p><p>[URL unfurl="true"]https://thinksteroids.com/articles/anabolic-steroids-heart-structure-function/[/URL]</p><p></p><p><em><strong>Conclusion</strong></em></p><p><em></em></p><p><em>Prolonged anabolic steroid use can affect the structure and function of the heart. These changes appear, at least partly, reversible after cessation of use. It’s hard to translate these findings to concrete numbers which express the risk of heart issues or even mortality with it. Nevertheless, it’s clear that these changes are detrimental to an AAS user’s health. <strong><em>As such, it seems advisable to take an annual echocardiographic assessment to monitor potentially unfavorable changes to cardiac structure and function.</em></strong></em></p><p></p><p></p><p>From direct experience I very much concur with the recommendation.</p></blockquote><p></p>
[QUOTE="tareload, post: 215858"] For the HAARLEM study above: [URL unfurl="true"]https://www.frontiersin.org/files/Articles/732318/frph-03-732318-HTML/image_m/frph-03-732318-t001.jpg[/URL] [HEADING=2][/HEADING] [HEADING=2]Clinical Relevance[/HEADING] Our findings strongly support the cardiotoxic nature of AAS. The changes in cardiac structure and function did not lead to symptoms, however, such as dyspnoea or peripheral oedema, as these were not reported by the subjects. The occurrence of heart failure in users of AAS nevertheless has often been reported ([URL='https://www.frontiersin.org/articles/10.3389/frph.2021.732318/full#B22']22[/URL]). We hypothesize that cumulative cardiac damage may follow long-standing AAS use when recovery time in between cycles is too short or when AAS are used continuously. Our data could not substantiate the presence of such cumulative damage as we did not observe a relationship between the extent of prior AAS use and cardiac abnormalities at baseline. Of note, our cohort displayed a wide variety of historic AAS use, ranging from no prior use to 8 years of cumulative AAS use, but no subjects had abused androgens continuously for longer than 1 year. It is therefore likely that progression to clinical heart failure only occurs in those athletes with an excessive history of AAS use, or when an athlete has a prior medical condition affecting the heart, e.g., cardiomyopathy. Heart Primer and review of above article. [URL unfurl="true"]https://thinksteroids.com/articles/anabolic-steroids-heart-structure-function/[/URL] [I][B]Conclusion[/B] Prolonged anabolic steroid use can affect the structure and function of the heart. These changes appear, at least partly, reversible after cessation of use. It’s hard to translate these findings to concrete numbers which express the risk of heart issues or even mortality with it. Nevertheless, it’s clear that these changes are detrimental to an AAS user’s health. [B][I]As such, it seems advisable to take an annual echocardiographic assessment to monitor potentially unfavorable changes to cardiac structure and function.[/I][/B][/I] From direct experience I very much concur with the recommendation. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Clinical Use of Anabolics and Hormones
Clinical Use of Anabolics and Hormones
TRT to Supraphysiological Levels for Body Building
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top